Nanocomposite membranes with Au nanoparticles for dialysis-based catalytic reduction-separation of nitroaromatic compounds [PDF]
Apart from the fact that nitroaromatic compounds (NARs) have toxic and mutagenic characteristics, they are also essential substrates for the synthesis of aromatic amines (AAMs). In this context, the present study presents a new approach that enables NAR-contaminated wastewaters to be treated as a reagent for the synthesis of AAMs.
arxiv +1 more source
Hydrothorax Complicating Peritoneal Dialysis, a Case Report [PDF]
Hydrothorax is a rare but serious complication of peritoneal dialysis. We report a recurrent pleural effusion in a case of ESRD (end stage renal disease) treated by pleurodesis using tetracycline. Key words: Sweet pleural effusion.
Hoseini, Rozita+2 more
core +2 more sources
Peritoneal dialysis in children after cardiopulmonary bypass [PDF]
Objective: We reviewed 5 years' experience with peritoneal dialysis in children with acute renal failure after cardiac operations. We hypothesized that peritoneal dialysis is safe and effective in children with low-output cardiac failure after cardiac ...
LeBlanc, Jacques G.+3 more
core +1 more source
Calciphylaxis: A successful outcome whilst on peritoneal dialysis
Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar+5 more
doaj +1 more source
Sarcopenia ‘made simple’ and outcomes from emergency laparotomy
CT‐assessed ratio of L3 vertebral body cross‐sectional area to total psoas muscle cross‐sectional area (L3:PM) is a simple yet significant predictor of 30‐, 90‐ and 365‐day mortality in emergency laparotomy patients. This study is the first to describe the association in an Australian population.
Yan Joyce Ming+4 more
wiley +1 more source
Background Urinary mitochondrial DNA (mtDNA) fragment level has been proposed as a biomarker of chronic kidney disease (CKD). In this study, we determine the relation between urinary mtDNA level and rate of renal function deterioration in non-diabetic ...
Zhongping WEI+7 more
doaj +1 more source
Chronic kidney disease affects approximately 14.3% of people worldwide. Tubulointerstitial fibrosis is the final stage of almost all progressive CKD. To date, the pathogenesis of renal fibrosis remains unclear, and there is a lack of effective treatments,
Jialin Li+12 more
doaj +1 more source
Recent advances in novel diagnostic testing for peritoneal dialysis-related peritonitis [PDF]
Peritoneal dialysis-related peritonitis remains a significant complication and an important cause of technique failure. Based on current International Society for Peritoneal Dialysis guidelines, diagnosis of peritonitis is made when two of the three ...
Winston Wing-Shing Fung+1 more
doaj +1 more source
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. [PDF]
Intraperitoneal vancomycin is the first-line therapy in the management of peritoneal dialysis (PD)-related peritonitis. However, due to the paucity of data, vancomycin dosing for peritonitis in patients on automated peritoneal dialysis (APD) is empiric ...
Kraft, Walter K.+6 more
core +1 more source
Comparison of Blood Pressure Control and Left Ventricular Hypertrophy in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) [PDF]
This study aimed to investigate the influence of different peritoneal dialysis regimens on blood pressure control, the diurnal pattern of blood pressure and left ventricular hypertrophy in patients on peritoneal dialysis.
Anderson+34 more
core +2 more sources